[1] Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting. [ For clinically guided warfarin dosing]
[2] Anand A, Kumar R, Sharma S, Gupta A, Vijayvergiya R, Mehrotra S, Kumar B, Lad D, Patil AN, Shafiq N, Malhotra S. Development and validation wise assessment of genotype guided warfarin dosing algorithm in Indian population. Drug Metab Pers Ther. 2023 Apr 19. doi: 10.1515/dmpt-2022-0189. Epub ahead of print. PMID: 37075481. [ For pharmacogenetically guided warfarin dosing]
[3] Anand A, Hegde NC, Chhabra P, Purohit J, Kumar R, Gupta A, Lad DP, Mohindra R, Mehrotra S, Vijayvergiya R, Kumar B, Sharma V, Malhotra P, Ahluwalia J, Das R, Patil AN, Shafiq N, Malhotra S. Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial. Ann Hematol. 2024 Jun;103(6):2133-2144. doi: 10.1007/s00277-024-05757-1. Epub 2024 Apr 18. PMID: 38634917.